Falang Database driver not enabled

Nanobiotix at the American Society of Clinical Oncology Gastrointestinal anual meeting

Nanobiotix presents fist promising data from phase I/II liver cancers trial of NBTXR3 at the American Society of Clinical Oncology Gastrointestinal anual meeting.